Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026)

Capricor Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 505.27% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 505.27% YoY), while the FY2025 annual figure was $1.2 million, up 423.0% from the prior year.
• Other Non-Current Assets was $1.5 million for Q1 2026 at Capricor Therapeutics, up from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.5 million in Q1 2026 to a low of $221700.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $426490.4 across 5 years, with a median of $268172.0 in 2022.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets dropped 17.33% in 2024, then soared 505.27% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then slipped by 17.33% to $221700.0 in 2024, then jumped by 423.0% to $1.2 million in 2025, then soared by 32.27% to $1.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.5 million (Q1 2026), $1.2 million (Q4 2025), and $488738.0 (Q3 2025), per Business Quant data.